You are here

Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Wien, , A-1090 Austria
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Invasive Candidiasis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

ICU patients with a diagnosis of documented candidemia or invasive candidiasis and
belonging to one or more of the following specific populations:

- Post-abdominal surgery.

- Elderly > 65 years old.

- Renal insufficiency / failure / hemodialysis.

- Solid tumor.

- Solid-organ (liver, kidney, lung, heart) transplant recipients.

- Hepatic insufficiency.

- Neutropenic including hematology oncology patients.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Patients with poor venous access that would preclude IV drug delivery or multiple blood
draws.

NCT00689338
Pfizer
Completed
Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now